Tough on Drugs

Naltrexone, an opioid antagonist approved in 1994 by the US Food and Drug Administration for alcohol-dependence treatment, can reduce relapse rates among AD patients. Research on naltrexone's effectiveness on nicotine dependence is less clear, although researchers believe it may be helpful for specific smoker subgroups. A new study has found that naltrexone can help non-AD smokers who drink heavily on a social basis.

Posted on Thu, 19 Mar 2009 00:00:00 EDT at http://www.sciencedaily.com/releases/200...161458.htm